We are live on ! Find out more
RC

RBF Capital Portfolio holdings

AUM $2.05B
1-Year Est. Return 29.64%
This Fund
S&P 500
This Quarter Est. Return
+15.57%
1 Year Est. Return
+29.64%
3 Year Est. Return
+141.07%
5 Year Est. Return
+189.1%
10 Year Est. Return
+995.74%
AUM
$852M
AUM Growth
+$85.7M
Cap. Flow
-$2.39M
Cap. Flow %
-0.28%
Top 10 Hldgs %
34.5%
Holding
443
New
32
Increased
34
Reduced
65
Closed
53

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$8.95M
2
PCG icon
PG&E
PCG
+$8.64M
3
WFC icon
Wells Fargo
WFC
+$5.9M
4
MSTR icon
Strategy Inc
MSTR
+$4.08M
5
DBD
Diebold Nixdorf Incorporated
DBD
+$3.45M

Top Sells

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$9.99M
2
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$9.43M
3
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$4.9M
4
WMT icon
Walmart Inc
WMT
+$4.86M
5
PEP icon
PepsiCo
PEP
+$4.56M

Sector Composition

Rank Sector Weight
1 Financials 35.25%
2 Consumer Discretionary 13.25%
3 Healthcare 8%
4 Industrials 7.96%
5 Technology 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALR
376
DELISTED
AlerisLife Inc
ALR
$49K 0.01%
4,958
-544
-10% -$4.64K
ASV
377
DELISTED
ASV Holdings, Inc. Common Stock
ASV
$46K 0.01%
16,801
– –
TRIB
378
Trinity Biotech
TRIB
$8.39M
$43K 0.01%
100
– –
SGMA
379
DELISTED
Sigmatron International
SGMA
$41K ﹤0.01%
14,141
– –
PERI icon
380
Perion Network
PERI
$386M
$33K ﹤0.01%
12,272
– –
VTGN icon
381
VistaGen Therapeutics
VTGN
$12.8M
$32K ﹤0.01%
833
– –
EVOL
382
DELISTED
Evolving Systems, Inc.
EVOL
$29K ﹤0.01%
24,496
– –
LYTS icon
383
LSI Industries
LYTS
$924M
$28K ﹤0.01%
10,836
– –
SRRA
384
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$28K ﹤0.01%
411
– –
TOO
385
DELISTED
Teekay Offshore Partners L.P.
TOO
$24K ﹤0.01%
20,000
– –
SCYX icon
386
SCYNEXIS
SCYX
$52M
$17K ﹤0.01%
139
– –
FRTX
387
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$16K ﹤0.01%
42
– –
BW icon
388
Babcock & Wilcox
BW
$1.39B
$13K ﹤0.01%
+3,143
New +$17.3K
AACG
389
ATA Creativity
AACG
$37.2M
$10K ﹤0.01%
10,427
– –
APVO icon
390
Aptevo Therapeutics
APVO
$5.21M
– –
0
– –
AFMD
391
DELISTED
Affimed
AFMD
– –
-1,610
Closed -$50K
ALLY icon
392
Ally Financial
ALLY
$13.3B
– –
-10,225
Closed -$232K
AOSL icon
393
Alpha and Omega Semiconductor
AOSL
$1.08B
– –
-10,900
Closed -$111K
AR icon
394
Antero Resources
AR
$10.7B
– –
-20,000
Closed -$188K
ARDX icon
395
Ardelyx
ARDX
$997M
– –
-72,693
Closed -$130K
BIDU icon
396
Baidu
BIDU
$37.2B
– –
-2,000
Closed -$317K
BV icon
397
BrightView Holdings
BV
$1.07B
– –
-135,800
Closed -$1.39M
CGEN icon
398
Compugen
CGEN
$228M
– –
-13,700
Closed -$30K
CODA icon
399
Coda Octopus Group
CODA
$120M
– –
-11,866
Closed -$69K
CPSS icon
400
Consumer Portfolio Services
CPSS
$206M
– –
-48,107
Closed -$145K
14 15
16
17 18

Similar funds

IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

RBF Capital's Q1 2019 Portfolio in Review

As of Q1 2019, RBF Capital held 443 positions worth $852M, up 11% from $766M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

RBF Capital's Q1 2019 filing shows 32 new, 34 increased, 65 reduced and 53 closed positions. Its largest new stake was PG&E: 535,000 shares worth $9.52M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $9.99M.

By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • RBF Capital's largest Q1 2019 buy was PG&E: 535,000 shares worth $9.52M.
  • RBF Capital added most to Bank of America in Q1 2019, an estimated $8.95M increase.
  • RBF Capital's biggest Q1 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $9.99M.
  • RBF Capital fully exited iShares Core MSCI Emerging Markets ETF in Q1 2019, selling an estimated $9.43M.
  • RBF Capital's ten largest holdings make up 34% of its $852M portfolio in Q1 2019.
  • RBF Capital opened 32 new positions and closed 53 in Q1 2019.
  • RBF Capital's portfolio value rose 11% quarter-over-quarter to $852M.

Based on RBF Capital's 13F filing for Q1 2019, filed 15 May 2019.